Literature DB >> 11513191

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.

H B El-Serag1, P A Richardson, J E Everhart.   

Abstract

OBJECTIVE: Diabetes mellitus (DM) has been reported to increase the risk of hepatocellular carcinoma (HCC). We carried out a case-control study to examine the role of DM while controlling for several known risk factors of HCC.
METHODS: All hospitalized patients with primary liver cancer (PLC) during 1997-1999 were identified in the computerized database of the Department of Veterans Affairs, the Patient Treatment File. Controls without cancer were randomly assigned from the Patient Treatment File during the same time period. The inpatient and outpatient files were searched for several conditions including DM, hepatitis C virus (HCV), hepatitis B virus (HBV), alcoholic cirrhosis, autoimmune hepatitis, hemochromatosis, and nonspecific cirrhosis. Adjusted odds ratios (OR) were calculated in a multivariable logistic regression model.
RESULTS: We identified 823 patients with PLC and 3459 controls. The case group was older (62 yr [+/-10] vs 60 [+/-11], p < 0.0001), had more men (99% vs 97%, 0.0004), and a greater frequency of nonwhites (66% vs 71%, 0.0009) compared with controls. However, HCV- and HBV-infected patients were younger among cases than controls. Risk factors that were significantly more frequent among PLC cases included HCV (34% vs 5%, p < 0.0001), HBV (11% vs 2%, p < 0.0001), alcoholic cirrhosis (47% vs 6%, p < 0.0001), hemochromatosis (2% vs 0.3%, p < 0.0001), autoimmune hepatitis (5% vs 0.5%, p < 0.0001), and diabetes (33% vs 30%, p = 0.059). In the multivariable logistic regression, diabetes was associated with a significant increase in the adjusted OR of PLC (1.57, 1.08-2.28, p = 0.02) in the presence of HCV, HBV, or alcoholic cirrhosis. Without markers of chronic liver disease, the adjusted OR for diabetes and PLC was not significantly increased (1.08, 0.86-1.18, p = 0.4). There was an increase in the HCV adjusted OR (17.27, 95% Cl = 11.98-24.89) and HBV (9.22, 95% CI = 4.52-18.80) after adjusting for the younger age of HCV- and HBV-infected cases. The combined presence of HCV and alcoholic cirrhosis further increases the risk with an adjusted OR of 79.21 (60.29-103.41). The population attributable fraction for HCV among hospitalized veterans was 44.8%, whereas that of alcoholic cirrhosis was 51%.
CONCLUSION: DM increased the risk of PLC only in the presence of other risk factors such as hepatitis C or B or alcoholic cirrhosis. Hepatitis C infection and alcoholic cirrhosis account for most of PLC among veterans.

Entities:  

Mesh:

Year:  2001        PMID: 11513191     DOI: 10.1111/j.1572-0241.2001.04054.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  65 in total

Review 1.  What primary care providers need to know about hepatocellular carcinoma.

Authors:  Parul Dureja Agarwal
Journal:  Clin Liver Dis (Hoboken)       Date:  2013-01-23

Review 2.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

Review 3.  Global epidemiology and burden of HCV infection and HCV-related disease.

Authors:  Aaron P Thrift; Hashem B El-Serag; Fasiha Kanwal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

4.  Alcohol, postprandial plasma glucose, and prognosis of hepatocellular carcinoma.

Authors:  Hiroshi Abe; Yuta Aida; Haruya Ishiguro; Kai Yoshizawa; Tamihiro Miyazaki; Munenori Itagaki; Satoshi Sutoh; Yoshio Aizawa
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

5.  An efficient model for auxiliary diagnosis of hepatocellular carcinoma based on gene expression programming.

Authors:  Li Zhang; Jiasheng Chen; Chunming Gao; Chuanmiao Liu; Kuihua Xu
Journal:  Med Biol Eng Comput       Date:  2018-03-16       Impact factor: 2.602

Review 6.  Fatty liver: a link to cardiovascular disease--its natural history, pathogenesis, and treatment.

Authors:  Howard P Monsour; Catherine T Frenette; Kathleen Wyne
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Jul-Sep

Review 7.  The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.

Authors:  Stephen Caldwell; Sang H Park
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

8.  Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans.

Authors:  M Mazen Jamal; Eugene J Yoon; Kenneth J Vega; Mehrtash Hashemzadeh; Kenneth J Chang
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

9.  Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy.

Authors:  Massimiliano Balbi; Valter Donadon; Michela Ghersetti; Silvia Grazioli; Giovanni Della Valentina; Rita Gardenal; Maria Dal Mas; Pietro Casarin; Giorgio Zanette; Cesare Miranda; Paolo Cimarosti
Journal:  Int J Environ Res Public Health       Date:  2010-03-29       Impact factor: 3.390

10.  Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas.

Authors:  Xiao-Ping Li; Zhen Chen; Zhi-Qiang Meng; Wen-Xia Huang; Lu-Ming Liu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.